Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05593900 · ClinicalTrials.gov registry record · NA

Nurse-To-Family Telehealth

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
291
Enrollment target

NCT05593900: Completed NA study, sponsored by University of California, Davis.

NCT05593900 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 291 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05593900, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
291 participants
Enrollment target

Study Summary

This study will be a pilot test of using telehealth to allow nurses to connect with parents/guardians of pediatric patients who are being transferred between hospitals.

Primary Outcome

Percentage of eligible patients for whom the protocol assignment (telehealth vs standard of care) was followed

Interventions

  • BEHAVIORAL Nurse-to-Family Video Chat

Trial Details

FieldValue
Enrollment Target 291 participants
Start Date 2023-01-03
Est. Completion 2023-07-23
Phase NA
University of California, Davis

657 total trials

What the finished NCT05593900 record still lists

NCT05593900 is an interventional study that assigns participants to a tested intervention. The registered 291 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).

The record links to 0 conditions, and to 1 intervention - of which Nurse-to-Family Video Chat is the first listed.

NCT05593900 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05593900 about?

NCT05593900 is a clinical study titled "Nurse-To-Family Telehealth". This study will be a pilot test of using telehealth to allow nurses to connect with parents/guardians of pediatric patients who are being transferred between hospitals.

What is the current status of trial NCT05593900?

This trial is currently completed. It is a NA study. The enrollment target is 291 participants. The study started on 2023-01-03. Estimated completion is 2023-07-23.

What interventions are being tested in trial NCT05593900?

The interventions under investigation include: Nurse-to-Family Video Chat (BEHAVIORAL).

Who is sponsoring clinical trial NCT05593900?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05593900's enrollment target sits among peer trials

291 375th of 2000 higher than 1,626 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02074839 · 291 participants · Phase 1

    Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

  • NCT03769766 · 291 participants · Phase 3

    Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

  • NCT06563479 · 291 participants · Phase 3

    A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat Cancer

  • NCT04429542 · 292 participants · Phase 1

    Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05593900, the US trial registry maintained by the National Library of Medicine. NCT05593900 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.